Second, it reinforces a documentation principle: Z codes should only appear when they add meaningful clinical information beyond what the primary code already communicates
Conducted between June 2011 and March 2013 at 191 sites in 27 countries in Europe, North America, South America, Asia, and Australia this was a randomised, placebo-controlled trial designed to evaluate the efficacy and safety of 3mg liraglutide 'injected subcutaneously once daily, as an adjunct to a reduced-calorie diet and increased physical activity, for weight management in overweight or obese adults who did not have diabetes at baseline.' A total of 3,731 individuals participated in the trial, of whom 2,487 were assigned to lifestyle intervention plus liraglutide and 1,244 to lifestyle intervention with a placebo
doi: 10.11648/j.crj.20210901.14 205 ShaughnessyDTMcAllisterKWorthLHaugenACMeyerJNDomannFEet al
Treatment options for nausea caused by GLP-1 medications may include: For severe or persistent nausea, consult your healthcare provider for alternative treatments or adjustments to your GLP-1 medication dosage
Both peptides have likewise been studied mostly in animal models, with limited human studies published to date
